Cvr Refng LP (CVRR) Holder Hite Hedge Asset Management Has Raised Holding by $2.09 Million as Share Price Declined; Abbvie (ABBV) Holder Palouse Capital Management Has Cut Its Holding by $3.95 Million

January 11, 2018 - By Adrian Mccoy

Hite Hedge Asset Management Llc increased its stake in Cvr Refng Lp (CVRR) by 22.26% based on its latest 2017Q3 regulatory filing with the SEC. Hite Hedge Asset Management Llc bought 232,347 shares as the company’s stock declined 6.85% while stock markets rallied. The hedge fund held 1.28M shares of the energy company at the end of 2017Q3, valued at $12.57M, up from 1.04 million at the end of the previous reported quarter. Hite Hedge Asset Management Llc who had been investing in Cvr Refng Lp for a number of months, seems to be bullish on the $2.47 billion market cap company. The stock increased 3.09% or $0.5 during the last trading session, reaching $16.7. About 372,270 shares traded. CVR Refining, LP (NYSE:CVRR) has declined 2.95% since January 11, 2017 and is downtrending. It has underperformed by 19.65% the S&P500.

Palouse Capital Management Inc decreased its stake in Abbvie Inc (ABBV) by 39.99% based on its latest 2017Q3 regulatory filing with the SEC. Palouse Capital Management Inc sold 44,915 shares as the company’s stock rose 6.17% with the market. The institutional investor held 67,410 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $5.99M, down from 112,325 at the end of the previous reported quarter. Palouse Capital Management Inc who had been investing in Abbvie Inc for a number of months, seems to be less bullish one the $158.04 billion market cap company. The stock increased 0.02% or $0.01 during the last trading session, reaching $99. About 2.57 million shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since January 11, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.

Investors sentiment decreased to 0.97 in 2017 Q3. Its down 0.03, from 1 in 2017Q2. It worsened, as 14 investors sold CVRR shares while 16 reduced holdings. 6 funds opened positions while 23 raised stakes. 17.89 million shares or 13.50% more from 15.76 million shares in 2017Q2 were reported. Art Lc invested in 67,061 shares or 0.03% of the stock. Advisory Ser Ltd Limited Liability Company has 737 shares for 0% of their portfolio. The Missouri-based Stifel Fincl Corporation has invested 0% in CVR Refining, LP (NYSE:CVRR). 59,150 were accumulated by Ameriprise Financial. Bnp Paribas Arbitrage Sa holds 0% of its portfolio in CVR Refining, LP (NYSE:CVRR) for 186,813 shares. Bank Of New York Mellon holds 0% in CVR Refining, LP (NYSE:CVRR) or 220,000 shares. Tower Research Ltd Llc (Trc) has 0.01% invested in CVR Refining, LP (NYSE:CVRR). Credit Suisse Ag holds 0% in CVR Refining, LP (NYSE:CVRR) or 11,517 shares. Creative Planning has 145,100 shares for 0.01% of their portfolio. Bessemer Grp Incorporated holds 0% or 4,000 shares in its portfolio. U S, a Texas-based fund reported 108,800 shares. Sumitomo Mitsui Tru holds 0% in CVR Refining, LP (NYSE:CVRR) or 45,000 shares. National Bank Of Montreal Can, Ontario – Canada-based fund reported 40,700 shares. First Advsrs Lp holds 0% or 52,537 shares. Yorkville Management Limited Liability Corp has 0.3% invested in CVR Refining, LP (NYSE:CVRR).

Among 10 analysts covering CVR Refining LP (NYSE:CVRR), 1 have Buy rating, 2 Sell and 7 Hold. Therefore 10% are positive. CVR Refining LP had 33 analyst reports since July 24, 2015 according to SRatingsIntel. Citigroup downgraded the stock to “Neutral” rating in Wednesday, October 21 report. JP Morgan downgraded the stock to “Underweight” rating in Friday, June 10 report. The company was maintained on Tuesday, August 2 by Barclays Capital. As per Wednesday, September 14, the company rating was maintained by Citigroup. The firm has “Overweight” rating by Barclays Capital given on Tuesday, January 12. As per Wednesday, October 18, the company rating was maintained by Citigroup. The stock of CVR Refining, LP (NYSE:CVRR) earned “Neutral” rating by UBS on Thursday, May 19. The firm has “Underweight” rating by Piper Jaffray given on Friday, July 1. The rating was maintained by Credit Suisse on Monday, April 11 with “Neutral”. The stock has “Underweight” rating by Piper Jaffray on Monday, August 22.

Hite Hedge Asset Management Llc, which manages about $778.61 million and $387.03M US Long portfolio, decreased its stake in Usd Partners Lp by 141,924 shares to 70,788 shares, valued at $779,000 in 2017Q3, according to the filing. It also reduced its holding in Enbridge Energy Management L (NYSE:EEQ) by 23,644 shares in the quarter, leaving it with 870,911 shares, and cut its stake in Williams Partners LP New (ACMP).

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on January, 26. They expect $1.43 earnings per share, up 19.17% or $0.23 from last year’s $1.2 per share. ABBV’s profit will be $2.28B for 17.31 P/E if the $1.43 EPS becomes a reality. After $1.41 actual earnings per share reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 1.42% EPS growth.

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 52% are positive. Abbvie Inc had 70 analyst reports since July 21, 2015 according to SRatingsIntel. Cowen & Co maintained the shares of ABBV in report on Friday, July 28 with “Hold” rating. The stock of AbbVie Inc. (NYSE:ABBV) earned “Hold” rating by Credit Suisse on Wednesday, June 7. UBS maintained the shares of ABBV in report on Friday, October 23 with “Buy” rating. Cowen & Co upgraded AbbVie Inc. (NYSE:ABBV) on Wednesday, October 11 to “Outperform” rating. The firm earned “Hold” rating on Wednesday, June 7 by BMO Capital Markets. The stock of AbbVie Inc. (NYSE:ABBV) earned “Buy” rating by Jefferies on Thursday, January 4. The firm has “Hold” rating by Credit Suisse given on Thursday, July 20. On Friday, August 18 the stock rating was maintained by Jefferies with “Buy”. Barclays Capital maintained it with “Equal-Weight” rating and $9 target in Friday, October 13 report. The stock has “Buy” rating by Piper Jaffray on Thursday, September 28.

Since July 31, 2017, it had 0 insider buys, and 8 insider sales for $45.57 million activity. On Monday, October 30 Gosebruch Henry O sold $1.66M worth of AbbVie Inc. (NYSE:ABBV) or 18,300 shares. Schumacher Laura J sold $14.07M worth of stock. Another trade for 6,699 shares valued at $589,512 was sold by Michael Robert A.. Another trade for 8,300 shares valued at $705,655 was made by SALEKI-GERHARDT AZITA on Monday, September 11. 87,040 shares valued at $8.57 million were sold by RICHMOND TIMOTHY J. on Monday, December 18.

Investors sentiment decreased to 0.85 in Q3 2017. Its down 0.15, from 1 in 2017Q2. It worsened, as 55 investors sold ABBV shares while 640 reduced holdings. 132 funds opened positions while 462 raised stakes. 1.06 billion shares or 1.89% more from 1.04 billion shares in 2017Q2 were reported. C Grp Holding A S, Denmark-based fund reported 143,271 shares. Harris Lp reported 61,050 shares or 0.01% of all its holdings. Harvey Invest Communications Limited Liability Co reported 110,938 shares stake. Alley Co Llc holds 1.36% or 42,086 shares in its portfolio. Torray Ltd accumulated 14,385 shares or 0.13% of the stock. Putnam Fl Investment Company owns 0.64% invested in AbbVie Inc. (NYSE:ABBV) for 75,884 shares. Iron Fin Lc reported 0.22% of its portfolio in AbbVie Inc. (NYSE:ABBV). Asset Management One Ltd holds 2.61M shares or 0.54% of its portfolio. Guardian Capital Limited Partnership stated it has 183,197 shares or 0.24% of all its holdings. Norinchukin National Bank The holds 224,626 shares or 0.39% of its portfolio. Wisconsin-based Dana Investment Advsr Incorporated has invested 1.59% in AbbVie Inc. (NYSE:ABBV). The Texas-based Ray Gerald L And Assoc Limited has invested 0.33% in AbbVie Inc. (NYSE:ABBV). Hancock accumulated 191,222 shares. Ghp Invest accumulated 5,515 shares. First Fincl Corp In reported 13,644 shares or 0.79% of all its holdings.